ARG1 and chronic myelogenous leukemia, BCR-ABL1 positive: The differences in Arg1 concentration between HD and CML patients at diagnosis was statistically significant (64±37,5 vs 243,9±64,3 ng/ml; p<0.0001) (fig.3C).